{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:42:27Z","timestamp":1648723347986},"reference-count":25,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.3892\/ijo.2013.1784","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T09:44:13Z","timestamp":1358847853000},"page":"1088-1092","source":"Crossref","is-referenced-by-count":3,"title":["Proteomic (antibody microarray) exploration of the molecular mechanism of action of the specific COX-2 inhibitor DuP 697"],"prefix":"10.3892","volume":"42","author":[{"given":"VIJAY","family":"AGARWAL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VICTORIA C.","family":"HODGKINSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GINA L.","family":"EAGLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUCY","family":"SCAIFE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHAEL J.","family":"LIND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LYNN","family":"CAWKWELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"key20180107180807_b1-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.ejca.2005.04.013","article-title":"Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?","volume":"41","author":"Hull","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180107180807_b2-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1470-2045(03)01220-8","article-title":"Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?","volume":"4","author":"Gasparini","year":"2003","journal-title":"Lancet Oncol"},{"key":"key20180107180807_b3-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal antiinflammatory drugs (NSAIDS): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J Pharm Pharm Sci"},{"key":"key20180107180807_b4-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1734-1140(10)70262-0","article-title":"COX-2 as a target for cancer chemotherapy","volume":"62","author":"Ghosh","year":"2010","journal-title":"Pharmacol Rep"},{"key":"key20180107180807_b5-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/1078-0432.CCR-09-0788","article-title":"Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward","volume":"16","author":"Menter","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107180807_b6-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/thx.2003.008912","article-title":"Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma","volume":"59","author":"Baldi","year":"2004","journal-title":"Thorax"},{"key":"key20180107180807_b7-ijo-42-03-1088","first-page":"1857","article-title":"Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma","volume":"8","author":"Edwards","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key20180107180807_b8-ijo-42-03-1088","first-page":"3696","article-title":"Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor","volume":"60","author":"Marrogi","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107180807_b9-ijo-42-03-1088","first-page":"1267","article-title":"Cox and mesothelioma: an overview","volume":"20","author":"Cardillo","year":"2005","journal-title":"Histol Histopathol"},{"key":"key20180107180807_b10-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.ejca.2005.04.019","article-title":"Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma","volume":"41","author":"O\u2019Kane","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180107180807_b11-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ijc.11710","article-title":"Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention","volume":"109","author":"Catalano","year":"2004","journal-title":"Int J Cancer"},{"key":"key20180107180807_b12-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lungcan.2009.04.008","article-title":"COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines","volume":"67","author":"O\u2019Kane","year":"2010","journal-title":"Lung Cancer"},{"key":"key20180107180807_b13-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J Med Chem"},{"key":"key20180107180807_b14-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107180807_b15-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107180807_b16-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejphar.2007.06.057","article-title":"Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697)","volume":"573","author":"Churchman","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"key20180107180807_b17-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00277-007-0385-4","article-title":"Dup-697, a specific COX-2 inhibitor, suppresses growth and induces apoptosis on K562 leukemia cells by cell-cycle arrest and caspase-8 activation","volume":"87","author":"Peng","year":"2008","journal-title":"Ann Hematol"},{"key":"key20180107180807_b18-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jprot.2011.02.014","article-title":"Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis","volume":"74","author":"Hodgkinson","year":"2011","journal-title":"J Proteomics"},{"key":"key20180107180807_b19-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1158\/1078-0432.CCR-07-1598","article-title":"BCL-2 family proteins: critical checkpoints of apoptotic cell death","volume":"13","author":"Danial","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107180807_b20-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/156800910791859515","article-title":"Bid stands at the crossroad of stress-response pathways","volume":"10","author":"Song","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107180807_b21-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases","volume":"30","author":"Strasser","year":"2011","journal-title":"EMBO J"},{"key":"key20180107180807_b22-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-06-0325","article-title":"Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma","volume":"66","author":"Kern","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107180807_b23-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/1055-9965.EPI-06-0216","article-title":"Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells","volume":"15","author":"Lou","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107180807_b24-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2006.11.032","article-title":"Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt\/GSK3beta\/NAG-1 pathway","volume":"251","author":"Pang","year":"2007","journal-title":"Cancer Lett"},{"key":"key20180107180807_b25-ijo-42-03-1088","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjc.6604049","article-title":"Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy","volume":"97","author":"Schonthal","year":"2007","journal-title":"Br J Cancer"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1784\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:10:33Z","timestamp":1515348633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,1,22]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.3892\/ijo.2013.1784"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1784","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}